---
figid: PMC4333878__13027_2014_516_Fig2_HTML
figtitle: EBV interaction with the Bcl family
organisms:
- Human gammaherpesvirus 4
- Human papillomavirus
- Human papillomavirus type 16
- Human betaherpesvirus 5
- Human gammaherpesvirus 8
- Human T-cell leukemia virus type I
- Human papillomavirus types
- Aurantiochytrium single-stranded RNA virus 01
- Human T-cell lymphotropic virus
- Human T-lymphotropic virus 2
- Saccharomyces cerevisiae
- Isodon rubescens
- Homo sapiens
- Mus musculus
- Xenopus laevis
- NA
- NA
pmcid: PMC4333878
filename: 13027_2014_516_Fig2_HTML.jpg
figlink: /pmc/articles/PMC4333878/figure/Fig2/
number: F2
caption: EBV interaction with the Bcl family. BHRF1 is the viral structural and functional
  homologue of the human proto-oncogene Bcl-2 and is able to blockcell death through
  repression of pro-apoptotic proteins BIM, PUMA, and BID and upregulation of Bcl-2
  [, ]. Activated BARF1 upregulates Bcl-2 protein levels []. LMP-1 upregulates Bcl-2
  expression through the NF-κB/c-JNK/AP-1 pathway, while LMP2A increases expression
  of Bcl-xL and Bcl-2 through the Ha-Ras, PI3K/Akt, NF-κB and Raf/MEK/ERK pathways,
  respectively []. BZLF1 represses CD74 and p65 resulting in downregulation of Bcl-2
  and Bcl-xL expression []. EBER1 and EBER2 allow c-MYC to stimulate oncogenesis and
  inhibit apoptosis [].
papertitle: Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of
  cancer.
reftext: Kenneth Alibek, et al. Infect Agent Cancer. 2014;9:44.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9575779
figid_alias: PMC4333878__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC4333878__F2
ndex: 17b0ab88-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4333878__13027_2014_516_Fig2_HTML.html
  '@type': Dataset
  description: EBV interaction with the Bcl family. BHRF1 is the viral structural
    and functional homologue of the human proto-oncogene Bcl-2 and is able to blockcell
    death through repression of pro-apoptotic proteins BIM, PUMA, and BID and upregulation
    of Bcl-2 [, ]. Activated BARF1 upregulates Bcl-2 protein levels []. LMP-1 upregulates
    Bcl-2 expression through the NF-κB/c-JNK/AP-1 pathway, while LMP2A increases expression
    of Bcl-xL and Bcl-2 through the Ha-Ras, PI3K/Akt, NF-κB and Raf/MEK/ERK pathways,
    respectively []. BZLF1 represses CD74 and p65 resulting in downregulation of Bcl-2
    and Bcl-xL expression []. EBER1 and EBER2 allow c-MYC to stimulate oncogenesis
    and inhibit apoptosis [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - POMP
  - CD40
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - CD74
  - HLA-C
  - NFKB1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - BID
  - MAPK8
  - MAPK9
  - MAPK10
  - JUN
  - EPHB2
  - MAPK1
  - MAPK3
  - BCL2L11
  - FOS
  - FOSB
  - JUNB
  - JUND
  - EIF2AK2
  - BBC3
  - APAF1
  - CASP8AP2
  - WDR19
  - BCL2
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - Pomp
  - Cd40
  - Cd74
  - Hras
  - Nfkbib
  - Nfkb1
  - Zhx2
  - Rela
  - Gorasp1
  - Mdk
  - Bid
  - Mapk8
  - Jun
  - Ephb2
  - Mapk1
  - Bcl2l11
  - Bcl2l1
  - Eif2ak2
  - Bbc3
  - Apaf1
  - Bcl2
  - Cancer
---
